Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Prolevi Bio AB
AB
Active
Org 5593559981
Iliongränden 74, 224 71
Lund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 4 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Prolevi Bio AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
EBITDA
SEK millions
0M
-1M
-1M
-2M
-2M
0M
2022
-2M
-200%
2023
-1M
+50%
2024
-1M
0%
2025
Income statement
SEK thousands
Item
2022
2023
2024
2025
Revenue
—
0
0
0
Staff expenses
—
—
—
−135
EBITDA
0
−1 867
−1 386
−1 186
Depreciation & amort.
—
−0
−0
—
EBIT
0
−1 867
−1 386
−1 186
Net financials
—
7
−68
−403
Profit before tax
0
−1 860
−1 454
−1 589
Tax
—
−0
−0
—
Net profit
—
−1 860
−1 454
−1 589
Balance sheet
SEK thousands
Item
2022
2023
2024
2025
Total assets
—
6 330
9 172
8 097
Equity
—
5 431
3 975
6 188
Long-term debt
—
300
4 393
308
Short-term debt
—
598
804
1 601
Total debt
—
898
5 197
1 910
Financial ratios
5-year trend
EBITDA margin
-118638500.0%
This company
15.8%
Market median
750876682% below market
2022
2025
Equity ratio
76.4%
This company
38.2%
Market median
100% above market
2022
2025
Return on equity
-25.7%
This company
18.4%
Market median
240% below market
2022
2025
Net profit margin
-158899000.0%
This company
8.1%
Market median
1961716149% below market
2022
2025
Asset turnover
0.00×
This company
1.12×
Market median
100% below market
2022
2025
Debt / equity
0.31×
This company
0.62×
Market median
50% below market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-12-01 – 2022-12-31
View
PDF
More on Prolevi Bio AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
